AJR Get Involved! Join ARRS Today
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carlos, R. C.
Right arrow Articles by Fendrick, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carlos, R. C.
Right arrow Articles by Fendrick, A. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
AJR 2003; 180:893-900
© American Roentgen Ray Society


Developing a Prediction Rule to Assess Hepatic Malignancy in Patients with Cirrhosis

Ruth C. Carlos1, H. Myra Kim2, Hero K. Hussain1, Issac R. Francis1, Hanh V. Nghiem1 and A. Mark Fendrick3

1 Department of Radiology, MRI Section, University of Michigan, 1500 E. Medical Center Dr., UH B2B311, Ann Arbor, MI 48109-0030.
2 Center for Statistical Consulting and Research, University of Michigan, Ann Arbor, MI 48109-0030.
3 Department of Medicine, University of Michigan, Ann Arbor, MI 48109-0030.

OBJECTIVE. The objectives of our study were to identify independent clinical, demographic, and MR imaging correlates of malignancy in patients with cirrhosis and to develop a predictive model based on identified correlates of malignancy.

MATERIALS AND METHODS. Sixty examinations of 58 patients with biopsy proof of lesions suggestive of hepatocellular carcinoma on MR imaging were retrospectively reviewed. The signal intensity of the lesion on T2-weighted imaging and dynamic gadoliniumenhanced imaging, the size of the lesion, and the number of suspicious lesions were recorded; in addition, patient age and sex, {alpha}-fetoprotein level, and hepatitis C viral genotype were noted. The association between malignancy and each predictor variable was evaluated using the chi-square test or the two-group t test. The final logistic regression model included the variables that were shown to have a significant association with malignancy and the clinically relevant predictors. We used the adjusted odds ratios to measure the strength of each association. The discriminant ability of the model for detecting hepatic malignancy was assessed using receiver operating characteristic curve analysis.

RESULTS. The prevalence of hepatic malignancy in our study population was 64%. The area under the receiver operating characteristic curve for the logistic regression model was 0.82. Venous washout (odds ratio = 9.2), {alpha}-fetoprotein level (odds ratio = 3.2), and number of lesions (odds ratio = 1.5) were significant predictors for malignancy (p < 0.05). When arterial enhancement and venous washout were either both present or both absent, {alpha}-fetoprotein level contributed little to the prediction of malignancy.

CONCLUSION. The MR characteristics of hepatic lesions during the dynamic venous phase in conjunction with the serum {alpha}-fetoprotein level and number of lesions are predictors of hepatic malignancy. The use of these predictors can facilitate explicit estimation of malignancy in individuals with underlying cirrhosis, potentially improving clinical decision-making.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
B. B. Frericks, C. Loddenkemper, A. Huppertz, S. Valdeig, A. Stroux, M. Seja, K.-J. Wolf, and T. Albrecht
Qualitative and Quantitative Evaluation of Hepatocellular Carcinoma and Cirrhotic Liver Enhancement Using Gd-EOB-DTPA
Am. J. Roentgenol., October 1, 2009; 193(4): 1053 - 1060.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
J. M. Willatt, H. K. Hussain, S. Adusumilli, and J. A. Marrero
MR Imaging of Hepatocellular Carcinoma in the Cirrhotic Liver: Challenges and Controversies
Radiology, May 1, 2008; 247(2): 311 - 330.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
S. Bixby, R. Tello, and E. Kuligowska
Presence of a Yolk Sac on Transvaginal Sonography Is the Most Reliable Predictor of Single-Dose Methotrexate Treatment Failure in Ectopic Pregnancy
J. Ultrasound Med., May 1, 2005; 24(5): 591 - 598.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
H. K. Hussain, I. Syed, H. V. Nghiem, T. D. Johnson, R. C. Carlos, W. J. Weadock, and I. R. Francis
T2-weighted MR Imaging in the Assessment of Cirrhotic Liver
Radiology, March 1, 2004; 230(3): 637 - 644.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Roentgen Ray Society.